Related Experiment Video
Updated: Jul 17, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
New insight into BRAF mutations in cancer
Nathalie Dhomen1, Richard Marais
1Institute of Cancer Research, Cancer Research UK Centre for Cell and Molecular Biology, 237 Fulham Road, London, SW3 6JB, UK.
Current Opinion in Genetics & Development
|January 9, 2007
Summary
The RAS-RAF-MEK-ERK pathway, particularly BRAF mutations, is crucial in human cancers like melanoma. Understanding these mutations aids in diagnosing and treating cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The RAS-RAF-MEK-ERK signaling cascade is implicated in cell proliferation and cancer development.
- RAF, specifically BRAF, is frequently mutated in human cancers, notably melanoma.
Purpose of the Study:
- To explore the role of BRAF mutations in human cancers, including melanoma.
- To investigate novel insights from rare BRAF mutants and germline mutations.
- To understand the influence of UV exposure and genetic susceptibility on BRAF mutations.
Main Methods:
- Analysis of genetic profiling and microarray data.
- Review of studies on BRAF mutations in melanoma and genetic syndromes.
- Investigation of UV exposure's role in BRAF mutation induction.
Main Results:
- Activating BRAF mutations are common in melanoma (approx. 70%).
- Rare BRAF mutants provide insights into RAF signaling networks.
- Germline BRAF mutations are associated with rare genetic syndromes.
- UV exposure type influences BRAF mutation induction in melanoma.
Conclusions:
- BRAF mutations are key drivers in various human cancers, especially melanoma.
- Understanding BRAF alterations is vital for cancer diagnosis and therapeutic strategies.
- Further research into BRAF signaling networks and genetic factors may reveal new treatment avenues.
More Related Videos
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Related Concept Videos
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...